PF-Atlas › Clinical Trials › NCT04938726

Ketone Supplementation in Cystic Fibrosis

Ketone Monoester · Not specified

Registry ID
NCT04938726
Phase
Not specified
Status
Completed
Drug / intervention
Ketone Monoester
Sponsor
University of Alabama at Birmingham
Start
2021-11-01
Enrollment
15
Locations
1

About this trial

This study will examine the effects of a novel ketone monester supplement on patients with cystic fibrosis experiencing an acute pulmonary exacerbation requiring hospitalization. Patients will undergo standard testing along with blood sampling to examine concentrations of inflammatory markers. Patients will then receive the ketone supplement for 5 days followed by post-testing to examine changes in pulmonary function and inflammatory markers

View NCT04938726 on ClinicalTrials.gov →

Explore related

All Ketone Monoester trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT04938726 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.